Tempus AI, Inc. (NASDAQ:TEM) EVP Sells $603,947.30 in Stock

Tempus AI, Inc. (NASDAQ:TEM) EVP Andrew Polovin sold 13,135 shares of the business’s stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $45.98, for a total value of $603,947.30. Following the completion of the sale, the executive vice president now directly owns 154,171 shares of the company’s stock, valued at approximately $7,088,782.58. The trade was a 7.85 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Tempus AI Price Performance

Shares of TEM stock opened at $51.35 on Friday. The stock has a 50 day moving average of $56.35 and a 200-day moving average of $51.40. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. Tempus AI, Inc. has a 12 month low of $22.89 and a 12 month high of $91.45.

Analyst Ratings Changes

A number of brokerages have issued reports on TEM. Wolfe Research cut Tempus AI from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, February 26th. Bank of America upped their target price on Tempus AI from $54.00 to $60.00 and gave the stock a “neutral” rating in a research report on Monday, March 3rd. JPMorgan Chase & Co. cut Tempus AI from an “overweight” rating to a “neutral” rating and upped their target price for the stock from $50.00 to $55.00 in a research report on Tuesday, February 25th. Piper Sandler decreased their target price on Tempus AI from $70.00 to $55.00 and set a “neutral” rating for the company in a research report on Tuesday, March 4th. Finally, William Blair reaffirmed a “market perform” rating on shares of Tempus AI in a research report on Tuesday, February 25th. Six investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $61.18.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of TEM. Operose Advisors LLC acquired a new position in shares of Tempus AI in the fourth quarter valued at $25,000. First Horizon Advisors Inc. acquired a new position in shares of Tempus AI in the third quarter valued at $30,000. Farther Finance Advisors LLC acquired a new position in shares of Tempus AI in the fourth quarter valued at $34,000. Prestige Wealth Management Group LLC raised its stake in shares of Tempus AI by 910.4% in the fourth quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock valued at $36,000 after purchasing an additional 965 shares in the last quarter. Finally, NewEdge Advisors LLC acquired a new position in shares of Tempus AI in the fourth quarter valued at $49,000. 24.22% of the stock is currently owned by institutional investors and hedge funds.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.